Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tango Therapeutics Inc.

1.46
-0.0100-0.68%
Volume:461.71K
Turnover:673.84K
Market Cap:157.84M
PE:-1.22
High:1.51
Open:1.48
Low:1.43
Close:1.47
Loading ...

Analysts Are Bullish on These Healthcare Stocks: GeoVax Labs (GOVX), Tango Therapeutics (TNGX)

TIPRANKS
·
16 Apr

Tango Therapeutics Price Target Maintained With a $13.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Apr

Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline with Five Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025

GlobeNewswire
·
26 Mar

Tango Therapeutics (TNGX) Receives a Buy from Barclays

TIPRANKS
·
02 Mar

Tango Therapeutics Full Year 2024 Earnings: Revenues Disappoint

Simply Wall St.
·
28 Feb

Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
27 Feb

BRIEF-Tango Therapeutics Q4 Basic EPS USD -0.35

Reuters
·
27 Feb

Tango Therapeutics Q4 Basic EPS USD -0.35

THOMSON REUTERS
·
27 Feb

Press Release: Tango Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Highlights

Dow Jones
·
27 Feb

One Tango Therapeutics Insider Raised Stake By 400% In Previous Year

Simply Wall St.
·
08 Feb

Tango Therapeutics to Present at the Guggenheim SMID Cap Biotechnology Conference

GlobeNewswire
·
30 Jan

Is Tango Therapeutics (NASDAQ:TNGX) In A Good Position To Invest In Growth?

Simply Wall St.
·
05 Dec 2024

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
03 Dec 2024

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
03 Dec 2024

Tango Therapeutics treatment of pancreatic cancer granted orphan designation

TIPRANKS
·
27 Nov 2024

Tango Therapeutics Inc. (TNGX): Among the Most Promising Cancer Stocks According to Hedge Funds

Insider Monkey
·
23 Nov 2024

B. Riley Adjusts Price Target on Tango Therapeutics to $8 From $16, Maintains Buy Rating

MT Newswires Live
·
11 Nov 2024

Tango Therapeutics Inc : Guggenheim Cuts Target Price to $8 From $18

THOMSON REUTERS
·
07 Nov 2024

Barclays Keeps Their Buy Rating on Tango Therapeutics (TNGX)

TIPRANKS
·
07 Nov 2024

Tango Therapeutics Inc : Leerink Partners Cuts Target Price to $10 From $19

THOMSON REUTERS
·
07 Nov 2024